View More

Expansion of Arthroplasty Surgery Robot 'CUVIS-joint' into Myanmar

CUREXO's artificial joint surgery robot, 'CUVIS-joint', has obtained local regulatory approval from the Department of Food and Drug Administration (FDA) of Myanmar.CUREXO's partner in Myanmar is Zeya & Associates Co., Ltd., an EPC and engineering company specializing in the energy (power), medical, and industrial sectors.Based on this Myanmar approval, CUREXO plans to expand its entry into emerging countries by taking the lead in the Southeast Asian medical robot market.

View More

40th Annual Meeting of NASS in Denver

CUREXO participated in the 40th Annual Meeting of the North American Spine Society (NASS) held in Denver, USA, from November 14 to 16. At the exhibition, CUREXO, in collaboration with CGBio, showcased its spinal surgery robot CUVIS-Spine and spinal navigation system to local medical professionals and global partners. CUREXO plans to continue strengthening its foundation for expanding its presence in the spinal surgery robotics field and further develop partnerships across North America.

View More

CUREXO Turns Profitable in Q3 and Diversifies Global Medical Robot Revenue Base

• Cumulative sales of KRW 53.7 billion, up 30% year-on-year• Medical robot segment revenue up 80% year-on-year• Sales network expanded to Japan, Taiwan, Indonesia, Malaysia and PakistanSeoul, Republic of Korea – CUREXO Inc. (KOSDAQ: 060280), a medical robotics specialist, announced that it recorded an operating profit of KRW 9.7 billion on a consolidated basis in the third quarter, turning profitable compared with the same period last year.The company reported cumulative consolidated sales of KRW 53.7 billion for the first three quarters, representing a 30% increase year-on-year. In particular, cumulative revenue from its core medical robot business grew by 80% over the same period last year, driving both top-line growth and improved profitability.Operating profit for the third quarter came in at KRW 9.7 billion, marking a turnaround from both the prior-year quarter and the previous quarter and signaling a clear improvement in earnings quality.CUREXO explained that its performance was primarily supported by the diversification of its global medical robot sales portfolio. In 2024, the company expanded sales into new overseas markets including Japan, Taiwan, Indonesia, Malaysia and Pakistan, thereby broadening and stabilizing its international revenue base. The company also noted that sales in India, which were temporarily sluggish last year, have started to recover.A CUREXO spokesperson said,"Once we obtain regulatory approvals for CUVIS-joint in the United States (FDA), Europe (CE), and in markets such as the Middle East and Latin America, we expect to generate additional medical robot sales. We will continue to expand our presence in global markets and aim to maintain mid- to long-term growth momentum."

View More

CUVIS-joint in Japan

The first installation of Cuvis-joint in Japan has been completed at Tachibana Hospital, where the initial surgery using CUVIS-joint was successfully performed today, led by Dr. Kashiwagi.Our sincere thanks go to Tachibana Hospital, Dr. Kashiwagi, our valued partner Kyocera Medical Corporation, and the dedicated CUREXO team for their collaboration and efforts.This achievement marks an important step in expanding the global presence of CUVIS-joint and advancing precision and safety in orthopedic surgery through innovative robotic technology.

View More

KARM 2025

The 53rd Annual Meeting and International Conference of The Korean Academy of Rehabilitation Medicine(KARM 2025) was held from October 24(Fri) to 25(Sat) at the Grand Hyatt Incheon.CUREXO Inc. showcased its rehabilitation robot MorningWalk and engaged in consultations with various professionals in the field.In particular, MorningWalk users showed great interest in the newly introduced Propulsion Force Feedback System(PFF System), experiencing the system firsthand and sharing active feedback during the event.MorningWalk's PFF System ㅡis an optimized solution for intensive propulsion force training in gait rehabilitation ✔️ Advanced Robotic 3DoF arms continuously measure and train propulsive force ✔️ Unique foot plate joints offer exceptionally high freedom ✔️ Non-constraining saddle design ✔️ Timing-focused, feedback-driven VR module

View More

KOA 2025

CUREXO Inc. participated in the 69th Annual Congress of the Korean Orthopaedic Association (KOA 2025), held at COEX Magok from October 16 (Thu) to 18 (Sat), 2025. During the congress, CUREXO showcased the CUVIS-joint (THA), which recently received approval from the Ministry of Food and Drug Safety (MFDS), and had meaningful interactions with domestic and international medical professionals and stakeholders. CUVIS-joint (THA) is currently in the process of obtaining U.S. FDA and European CE certifications, as CUREXO continues to pursue global market expansion.

View More

CUREXO Secures Domestic Approval for Total Hip Arthroplasty (THA) Robot 'CUVIS-joint THA'

• Expansion of Indications from Knee to Hip Surgerical Robots… Enhanced Surgical Accuracy and Convenience with AI Medical robotics company CUREXO announced on the 2nd that it has obtained product approval from the Ministry of Food and Drug Safety (MFDS) for its total hip arthroplasty (THA) surgical robot, "CUVIS-joint THA." With this approval, CUREXO has expanded its product portfolio by adding hip indications to its existing knee joint replacement surgical robot, "CUVIS-joint." CUVIS-joint THA is equipped with AI-based automatic segmentation of hip CT images, surgical planning software, precision robotic control technology, and a user-friendly UI to enhance surgical convenience. (CUVIS-joint THA, photo = CUREXO) Based on this domestic approval, CUREXO plans to accelerate its global market entry by also pursuing overseas certifications, including the U.S. FDA and European CE approval for hip surgery. A CUREXO representative stated, "By integrating AI and robotic control technology, we have improved surgical accuracy and user convenience. We will continue to invest in R&D to strengthen our competitiveness in the global surgical robot market."

View More

AIRIS 2025 (AI Regulatory & International Symposium)

CUREXO, a leading medical robotics company, showcased its CUVIS-joint, an advanced joint replacement surgical robot, at AIRIS 2025 (AI Regulatory & International Symposium) held in September 2025.AIRIS 2025, co-hosted with the World Health Organization (WHO), brings together global regulatory authorities, industry leaders, and academic experts to discuss the latest technological trends and innovative cases in AI-based medical products. The symposium also features presentations from regulatory officials sharing their experiences in approval processes and providing insights into the future of AI regulation.- Event Name: AIRIS 2025 (AI Regulatory & International Symposium)- Theme: Regulation for AI, Together for Tomorrow- Hosts: Ministry of Food and Drug Safety (MFDS), WHO- Date: September 10 (Wed) – 12 (Fri), 2025- Venue: Inspire Resort, Incheon, Korea

View More

Curexo Presents Morning Walk Research Findings at AOCPRM

From August 21 to 23, Curexo participated in the 9th Asia Oceanian Conference of Physical and Rehabilitation Medicine (AOCPRM) held in Malaysia, where it presented research findings on its gait rehabilitation robot, Morning Walk.   The presentation highlighted that training using Morning Walk's Propulsion Force Feedback (PFF) system was effective in improving patients' gait propulsion, and that joint movement patterns observed during gait training with Morning Walk were similar to those of actual overground walking. This presentation served as an opportunity to demonstrate the clinical value of Morning Walk on an international stage, and Curexo will continue to strengthen its presence in the global rehabilitation robot market.

View More

CUREXO Supplies "CUVIS-joint" Artificial Joint Surgery Robot to Indonesia's Largest Hospital

• Expanding Global Presence with Advanced Medical Robotics Seoul, Korea – CUREXO, Inc. (CEO: Jae-Jun Lee), a leading medical robotics company, announced that it has successfully supplied its CUVIS-joint, an artificial joint surgical robot, to Indonesia's largest hospital.CUVIS-joint is designed to support surgeons in performing precise joint replacement surgeries by providing accurate preoperative planning and optimized surgical guidance. Through advanced 3D modeling, the system enables tailored surgical plans for individual patients, improving accuracy, consistency, and overall outcomes. The adoption of CUVIS-joint by Indonesia's largest hospital marks an important step in expanding access to cutting-edge robotic surgery across Southeast Asia. With the increasing demand for joint replacement procedures in the region, the introduction of this innovative solution is expected to significantly enhance surgical quality and patient recovery. A CUREXO spokesperson stated: "By supplying CUVIS-joint to Indonesia's leading hospital, we are accelerating our global expansion strategy. We will continue to strengthen our presence in international markets, providing innovative solutions that advance surgical precision and improve patient quality of life." CUREXO currently offers a diverse portfolio of advanced medical robots, including the CUVIS-spine, a spine surgical robot, and the Morning Walk, a rehabilitation robot. With proven technology and clinical performance, the company continues to solidify its leadership in the global medical robotics market.